Pushing Boundaries in Adhesive Innovation
ChemenceⓇ introduces the ExofinⓇ Precision Pen, a new medical device for wound closure that gives medical providers greater versatility and precision in closing wounds.
2022
Improving Patient Care
ChemenceⓇ launches a redesigned Exofin FusionⓇ skin closure system with a curved mesh design that enhances wound closure and healing and improves patient outcomes.
2019
GROWING KRYLEX®
Chemence® further focuses on high end manufacturing by acquiring Supreme Resources’ electronics adhesive business.
CONTINUOUS IMPROVEMENT
Chemence Inc. and Ltd. upgrade to ISO9001:2015 quality standards.
2018
FDA Clearance on Groundbreaking Products
ChemenceⓇ receives FDA approval for ExofinⓇ High Viscosity Tissue Adhesive, a topical skin adhesive with the highest viscosity formulation in the industry.
2016
ANOTHER EXPANSION
Chemence® relaunches KRYLEX® adhesive line for industrial manufacturing focusing on specialty markets such as electronics, medical devices and electric vehicles.
2015
INTRODUCING NEW PRODUCTS
Chemence® introduces KRYLEX®, its own formulation based on Ritelok developed in-house and later sold to 3M.
2015
EXTENDING OUR REACH
CMPI adds in-house molding capabilities further maintaining the integrity of our internally manufactured adhesives and packaging.
ESTABLISHING A GLOBAL PRESENCE
Chemence® purchases platemaking shops across Europe, including MediaFlex in Spain, VW Graphics and Outline Imaging in the UK. A strategic partnership with Smurt Kappas’ European trade shops is formed.
2014
SPREADING INTO MORE AREAS
Chemence® purchases Indiana Clearstamp, relocates the facility to Dalton, GA, and opens a photopolymer platemaking facility for the craft and hobby industry, one of only a few of its kind in the US, under the name “Clearstamp by Crati.”
2011
ADDING EVEN MORE INDUSTRIAL FIREPOWER
Chemence® acquires Polybron’s liquid photopolymer business.
2000
TAKING INNOVATION TO NEW LEVELS
Chemence® Inc. becomes QS-9000 compliant and a key supplier to Tier 1 and 2 OEMs.
BREAKING NEW GROUND… AND SAVING LIVES
CMPI creates and develops a patented variant of superglue used to repair inoperable aneurysms in the brain.
1998
EXPANDING INTO NEW FIELDS
Chemence Medical Products® Inc. is formed, and manufactures its own product line of medical adhesives, as well as those of other medical companies, to this day.
1994
NEW HOME, BIGGER FACILITY, BRIGHTER FUTURE
Chemence® Inc. relocates to a 100,000-square-foot manufacturing facility in Georgia, and becomes the only manufacturer of cyanoacrylate in the continental United States.
1993
Branching out to America
Chemence® Inc. was formed in Ohio, with the intent of becoming a distributor for companies based in the United States.
1989
A COMPANY IS FORMED, AND AN INNOVATOR ARRIVES
Founder Hugh V. Cooke established Chemence® Ltd. in the United Kingdom, as a specialty manufacturer of industrial adhesives and sealants.